Longeveron® to Present at the Virtual Life Sciences Investor Forum on June 20, 2024
Longeveron(LGVN) Newsfilter·2024-06-17 13:00Details for the Company's participation: About Longeveron Inc. Derek Cole Investor Relations Advisory Solutions derek.cole@iradvisory.com MIAMI, June 17, 2024 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, including hypoplastic left heart syndrome (HLHS) and Alzheimer's disease, today announced that it will participate in the Virtual Life Sciences Investor ...